In patients affected with adrenocortical carcinoma (ACC), C-X-C motif chemokine receptor 4 (CXCR4) is highly expressed in sites of disease in an ex-vivo setting. The gene discussed is CXCR4; the disease is adrenal cortex carcinoma.